These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 34251317

  • 1. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.
    Atas N, Eroglu GA, Sodan HN, Ozturk BO, Babaoglu H, Satis H, Karadeniz H, Guler AA, Salman RB, Goker B, Ozturk MA, Haznedaroglu S, Tufan A.
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):30-36. PubMed ID: 34251317
    [Abstract] [Full Text] [Related]

  • 2. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y, Gezer HH, Duruöz MT.
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [Abstract] [Full Text] [Related]

  • 3. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Tufan A, Haznedaroglu S.
    J Clin Rheumatol; 2020 Jan 30; 26(1):7-13. PubMed ID: 30048391
    [Abstract] [Full Text] [Related]

  • 5. Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab.
    Druyan A, Giat E, Livneh A, Grossman C, Ben-Zvi I, Lidar M.
    Clin Exp Rheumatol; 2021 Jan 30; 39 Suppl 132(5):75-79. PubMed ID: 34369359
    [Abstract] [Full Text] [Related]

  • 6. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct 30; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
    Erkilet HK, Gezgin Yildirim D, Esmeray P, Söylemezoğlu O.
    Pediatr Int; 2023 Oct 30; 65(1):e15588. PubMed ID: 37658625
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The clinical role of anakinra in the armamentarium against familial Mediterranean fever.
    Parlar K, Ates MB, Egeli BH, Ugurlu S.
    Expert Rev Clin Immunol; 2024 May 30; 20(5):441-453. PubMed ID: 38133629
    [Abstract] [Full Text] [Related]

  • 14. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S.
    Front Immunol; 2020 May 30; 11():971. PubMed ID: 32670263
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
    Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y.
    J Nephrol; 2018 Jun 30; 31(3):453-455. PubMed ID: 29446001
    [Abstract] [Full Text] [Related]

  • 18. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S, Dogantan S, Edeer Karaca N, Aksu G, Kutukculer N.
    Rheumatol Int; 2020 Jan 30; 40(1):161-168. PubMed ID: 31273456
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study.
    Mirioglu S, Dirim AB, Bektas M, Demir E, Tor YB, Ozluk Y, Kilicaslan I, Oto OA, Yalcinkaya Y, Caliskan Y, Artim-Esen B, Yazici H, Inanc M, Turkmen A, Gul A, Sever MS.
    Nephrol Dial Transplant; 2023 May 04; 38(5):1327-1336. PubMed ID: 36542475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.